These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33001413)

  • 1. Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring.
    Di Mario F; Regolisti G; Greco P; Maccari C; Superchi E; Morabito S; Pistolesi V; Fiaccadori E
    J Nephrol; 2021 Aug; 34(4):1271-1279. PubMed ID: 33001413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.
    Zakharchenko M; Los F; Brodska H; Balik M
    PLoS One; 2016; 11(7):e0158179. PubMed ID: 27391902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.
    Raina R; Chakraborty R; Davenport A; Brophy P; Sethi S; McCulloch M; Bunchman T; Yap HK
    Pediatr Nephrol; 2022 Oct; 37(10):2303-2330. PubMed ID: 34668064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
    Finkel KW; Foringer JR
    Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophosphatemia in critically ill patients undergoing Sustained Low-Efficiency Dialysis with standard dialysis solutions.
    Di Mario F; Regolisti G; Maggiore U; Pacchiarini MC; Menegazzo B; Greco P; Maccari C; Zambrano C; Cantarelli C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2022 Nov; 37(12):2505-2513. PubMed ID: 35481705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained low-efficiency dialysis with regional citrate anticoagulation in critically ill patients with COVID-19 associated AKI: A pilot study.
    Di Mario F; Regolisti G; Di Maria A; Parmigiani A; Benigno GD; Picetti E; Barbagallo M; Greco P; Maccari C; Fiaccadori E
    J Crit Care; 2021 Jun; 63():22-25. PubMed ID: 33611151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypomagnesemia as a risk factor for the non-recovery of the renal function in critically ill patients with acute kidney injury.
    Alves SC; Tomasi CD; Constantino L; Giombelli V; Candal R; Bristot Mde L; Topanotti MF; Burdmann EA; Dal-Pizzol F; Fraga CM; Ritter C
    Nephrol Dial Transplant; 2013 Apr; 28(4):910-6. PubMed ID: 22764195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional citrate anticoagulation: towards a first-choice treatment].
    Morabito S; Pistolesi V; Pierucci A
    G Ital Nefrol; 2012; 29(1):14-9. PubMed ID: 22388901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionized Magnesium and Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy.
    Zakharchenko M; Leden P; Rulíšek J; Los F; Brodska H; Balik M
    Blood Purif; 2016; 41(1-3):41-7. PubMed ID: 26960213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
    Costa E Silva VT; Caires RA; Bezerra JS; Costalonga EC; Oliveira APL; Oliveira Coelho F; Fukushima JT; Soares CM; Oikawa L; Hajjar LA; Burdmann EA
    J Crit Care; 2018 Oct; 47():302-309. PubMed ID: 29859647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional citrate anticoagulation during simulated treatments of sustained low efficiency diafiltration.
    Marshall MR; Ma TM; Eggleton K; Ferencz A
    Nephrology (Carlton); 2003 Dec; 8(6):302-10. PubMed ID: 15012701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.
    Fiaccadori E; Pistolesi V; Mariano F; Mancini E; Canepari G; Inguaggiato P; Pozzato M; Morabito S
    J Nephrol; 2015 Apr; 28(2):151-64. PubMed ID: 25585821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous KRT: A Contemporary Review.
    Teixeira JP; Neyra JA; Tolwani A
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):256-269. PubMed ID: 35981873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing of kidney replacement therapy initiation in acute kidney injury.
    Meraz-Muñoz AY; Bagshaw SM; Wald R
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):332-338. PubMed ID: 33767061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate anticoagulation for continuous renal replacement therapy.
    Kindgen-Milles D; Brandenburger T; Dimski T
    Curr Opin Crit Care; 2018 Dec; 24(6):450-454. PubMed ID: 30247214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
    Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
    J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.